184 related articles for article (PubMed ID: 30897285)
1. Role of HGF/c-Met in the treatment of colorectal cancer with liver metastasis.
Yao JF; Li XJ; Yan LK; He S; Zheng JB; Wang XR; Zhou PH; Zhang L; Wei GB; Sun XJ
J Biochem Mol Toxicol; 2019 Jun; 33(6):e22316. PubMed ID: 30897285
[TBL] [Abstract][Full Text] [Related]
2. Expression of HGF and Met in human tissues of colorectal cancers: biological and clinical implications for synchronous liver metastasis.
Sun YL; Liu WD; Ma GY; Gao DW; Jiang YZ; Liu Q; Du JJ
Int J Med Sci; 2013; 10(5):548-59. PubMed ID: 23532910
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer.
Bradley CA; Dunne PD; Bingham V; McQuaid S; Khawaja H; Craig S; James J; Moore WL; McArt DG; Lawler M; Dasgupta S; Johnston PG; Van Schaeybroeck S
Oncotarget; 2016 Nov; 7(48):78932-78945. PubMed ID: 27793046
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of aggressive hepatectomy for colorectal liver metastasis, evaluated from the HGF/c-Met pathway.
Matsui S; Osada S; Tomita H; Komori S; Mori R; Sanada Y; Takahashi T; Yamaguchi K; Yoshida K
Int J Oncol; 2010 Aug; 37(2):289-97. PubMed ID: 20596656
[TBL] [Abstract][Full Text] [Related]
5. X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling.
Takeuchi H; Kim J; Fujimoto A; Umetani N; Mori T; Bilchik A; Turner R; Tran A; Kuo C; Hoon DS
Clin Cancer Res; 2005 Nov; 11(21):7621-8. PubMed ID: 16278380
[TBL] [Abstract][Full Text] [Related]
6. [Association of expression of HGF and its receptor c-Met to primary colorectal cancers with synchronous liver metastasis].
Sun Y; Li Z; Xu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jun; 17(6):598-601. PubMed ID: 24953371
[TBL] [Abstract][Full Text] [Related]
7. Functional expression of HGF and its receptor in human colorectal cancer.
Otte JM; Schmitz F; Kiehne K; Stechele HU; Banasiewicz T; Krokowicz P; Nakamura T; Fölsch UR; Herzig K
Digestion; 2000; 61(4):237-46. PubMed ID: 10878450
[TBL] [Abstract][Full Text] [Related]
8. FOXC2 promotes colorectal cancer metastasis by directly targeting MET.
Cui YM; Jiao HL; Ye YP; Chen CM; Wang JX; Tang N; Li TT; Lin J; Qi L; Wu P; Wang SY; He MR; Liang L; Bian XW; Liao WT; Ding YQ
Oncogene; 2015 Aug; 34(33):4379-90. PubMed ID: 25381815
[TBL] [Abstract][Full Text] [Related]
9. Effect of hepatocyte growth factor on progression of liver metastasis in colorectal cancer.
Osada S; Matsui S; Komori S; Yamada J; Sanada Y; Ihawa A; Tanaka Y; Tokuyama Y; Okumura N; Nonaka K; Hosono Y; Takahashi T; Yamaguchi K; Yoshida K
Hepatogastroenterology; 2010; 57(97):76-80. PubMed ID: 20422876
[TBL] [Abstract][Full Text] [Related]
10. Activation of Src by c-Met overexpression mediates metastatic properties of colorectal carcinoma cells.
Herynk MH; Zhang J; Parikh NU; Gallick GE
J Exp Ther Oncol; 2007; 6(3):205-17. PubMed ID: 17552361
[TBL] [Abstract][Full Text] [Related]
11. Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer.
Zhang KL; Zhu WW; Wang SH; Gao C; Pan JJ; Du ZG; Lu L; Jia HL; Dong QZ; Chen JH; Lu M; Qin LX
Theranostics; 2021; 11(13):6560-6572. PubMed ID: 33995676
[No Abstract] [Full Text] [Related]
12. SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET.
Du F; Li X; Feng W; Qiao C; Chen J; Jiang M; Qiu Z; Qian M; Tian D; Nie Y; Fan D; Wu K; Xia L
Oncogene; 2020 Apr; 39(17):3522-3540. PubMed ID: 32111984
[TBL] [Abstract][Full Text] [Related]
13. Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis.
Fazekas K; Csuka O; Köves I; Rásó E; Tímár J
Clin Exp Metastasis; 2000; 18(8):639-49. PubMed ID: 11827067
[TBL] [Abstract][Full Text] [Related]
14. Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.
Bauer TW; Fan F; Liu W; Johnson M; Parikh NU; Parry GC; Callahan J; Mazar AP; Gallick GE; Ellis LM
Ann Surg; 2005 May; 241(5):748-56; discussion 756-8. PubMed ID: 15849510
[TBL] [Abstract][Full Text] [Related]
15. [Expression of hepatocyte growth factor/c-Met system in nasopharyngeal carcinoma and its biological significance].
Li Z; Lin SX; Liang HZ; He JH
Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):75-9. PubMed ID: 15842800
[TBL] [Abstract][Full Text] [Related]
16. u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma.
Tavian D; De Petro G; Benetti A; Portolani N; Giulini SM; Barlati S
Int J Cancer; 2000 Sep; 87(5):644-9. PubMed ID: 10925356
[TBL] [Abstract][Full Text] [Related]
17. CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET.
Wang S; Qiu J; Liu L; Su C; Qi L; Huang C; Chen X; Zhang Y; Ye Y; Ding Y; Liang L; Liao W
J Exp Clin Cancer Res; 2020 Aug; 39(1):168. PubMed ID: 32843066
[TBL] [Abstract][Full Text] [Related]
18. Predictive values of FAP and HGF for tumor angiogenesis and metastasis in colorectal cancer.
Ma TH; Gao CC; Xie R; Yang XZ; Dai WJ; Zhang JL; Yan W; Wu SN
Neoplasma; 2017; 64(6):880-886. PubMed ID: 28895412
[TBL] [Abstract][Full Text] [Related]
19. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.
Galeazzi E; Olivero M; Gervasio FC; De Stefani A; Valente G; Comoglio PM; Di Renzo MF; Cortesina G
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S138-43. PubMed ID: 9065649
[TBL] [Abstract][Full Text] [Related]
20. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
